SLC2A3 and teratoma: The latter clustering suggests a model in which tumors initially overexpress Glut1, Ldha, and Pfkfb3 (“Cluster 2”), implying teratoma growth, which is then followed by a downregulation of Glut3 and Aldoa (“Cluster 3”), putatively indicating immune cell suppression.